|
Oct 3
|
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
|
|
Aug 1
|
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
|
|
Jul 1
|
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
|
|
Jun 27
|
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
|
|
Jun 25
|
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
|
|
Jun 11
|
Sidoti Events, LLC's Virtual June Small-Cap Conference
|
|
Jun 10
|
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
|
|
Jun 6
|
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
|
|
Jun 4
|
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
|
|
May 23
|
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
|
|
Jan 10
|
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Share...
|
|
Dec 6
|
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
|
|
Nov 28
|
Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
|
|
Oct 11
|
Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference
|